Form 4: Cardlytics CFO Alexis DeSieno Receives Significant Equity Awards

Cardlytics, Inc. Chief Financial Officer Alexis DeSieno was granted 55,000 contingent equity awards, comprising Restricted Stock Units and Performance Stock Units, aligning her interests with shareholder value.

Summary

• Alexis DeSieno, Chief Financial Officer of Cardlytics, Inc. (CDLX), was granted equity awards on June 23, 2025.
• The awards include 40,000 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock.
• The RSU award vests 50% on June 23, 2026, with the remaining 50% vesting in equal quarterly amounts through June 23, 2027, contingent on continued employment.
• Additionally, 15,000 Performance Stock Units (PSUs) were granted, each representing a contingent right to receive one share of Common Stock.
• The PSU award vests based on the achievement of specified share price targets, also contingent on continued employment.
• The reported transaction value for both RSU and PSU grants was $0, as these are contingent rights to receive shares upon vesting.

Sentiment

Score: 7

Explanation: The document reports a standard equity grant to a key executive, which is generally positive as it aligns management incentives with shareholder interests. It does not contain any negative financial or operational news.

Positives

• The grant of Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) to the Chief Financial Officer aligns management's long-term interests with those of the shareholders, incentivizing performance and stock price appreciation.
• Equity-based compensation is a standard practice that helps retain key executives and motivates them to contribute to the company's success.

Future Outlook

The vesting of the Performance Stock Units (PSUs) is contingent upon the achievement of specified share price targets, indicating a future focus on increasing shareholder value.

Industry Context

The granting of equity awards like RSUs and PSUs is a common and standard practice across various industries, particularly in technology and growth-oriented companies, to compensate and incentivize key executives.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: The equity grants align the Chief Financial Officer's financial interests with shareholder value creation, potentially leading to improved long-term performance.
• Employees: The compensation structure for key executives may serve as a benchmark or incentive for other employees, though this specific filing focuses on one individual.

Next Steps

• Continued employment of Alexis DeSieno with Cardlytics, Inc. for the equity awards to vest.
• Achievement of specified share price targets for the Performance Stock Units (PSUs) to vest.
• Scheduled vesting of Restricted Stock Units (RSUs) on June 23, 2026, and quarterly through June 23, 2027.

Key Dates

Keywords

Cardlytics, CDLX, SEC Form 4, Insider Transaction, Equity Award, Restricted Stock Units, Performance Stock Units, CFO, Alexis DeSieno, Executive Compensation